Acquired BRAF N581S mutation mediated resistance to gefitinib and responded to dabrafenib plus trametinib

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Acquired BRAF N581S mutation mediated resistance to gefitinib and responded to dabrafenib plus trametinib
Authors
Keywords
BRAF N581S, Gefitinib, Dabrafenib, Trametinib
Journal
LUNG CANCER
Volume 146, Issue -, Pages 355-357
Publisher
Elsevier BV
Online
2020-06-09
DOI
10.1016/j.lungcan.2020.06.004

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.